Used in the synthesis of abiraterone acetate, a key pharmaceutical agent for treating castration-resistant prostate cancer. Acts as an intermediate in the production of steroidal compounds that inhibit androgen biosynthesis. Enables selective blocking of enzymes like CYP17A1, reducing testosterone levels in patients. Employed in research and development of oncology drugs due to its role in efficient synthetic pathways.